Autonomix Medical, Inc. (AMIX) analyst actions
Rating and price-target actions on AMIX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AMIX overview →
4 measured AMIX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System | Press release | +0.95% | +0.95% | |
| Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain | Press release | -7.47% | -2.90% | |
| Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones | Press release | +0.36% | -4.18% | |
| Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones | Press release | +0.00% | -12.95% |
Keep exploring
More AMIX: earnings → · SEC filings → · AMIX overview →